EA201791945A1 - Пирролидинкарбоксамидопроизводные и способы их получения и их применение - Google Patents

Пирролидинкарбоксамидопроизводные и способы их получения и их применение

Info

Publication number
EA201791945A1
EA201791945A1 EA201791945A EA201791945A EA201791945A1 EA 201791945 A1 EA201791945 A1 EA 201791945A1 EA 201791945 A EA201791945 A EA 201791945A EA 201791945 A EA201791945 A EA 201791945A EA 201791945 A1 EA201791945 A1 EA 201791945A1
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
methods
carboxamide derivatives
pyrrolidine carboxamide
derivatives
Prior art date
Application number
EA201791945A
Other languages
English (en)
Other versions
EA033342B1 (ru
Inventor
Гилдон Чои
Санг Дал Рхее
Имран Али
Чонг Хак Чае
Сеок Хее Парк
Мун Кук Джеон
Йоун Сук Ли
Квангхо Ли
Original Assignee
Ресерч Энд Бизнес Фондэйшн Сонгюнгван Юниверсити
Кореа Ресерч Инститьют Оф Кемикал Текнолоджи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ресерч Энд Бизнес Фондэйшн Сонгюнгван Юниверсити, Кореа Ресерч Инститьют Оф Кемикал Текнолоджи filed Critical Ресерч Энд Бизнес Фондэйшн Сонгюнгван Юниверсити
Publication of EA201791945A1 publication Critical patent/EA201791945A1/ru
Publication of EA033342B1 publication Critical patent/EA033342B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Пирролидинкарбоксамидопроизводные, их оптические изомеры и их соли, которые способны предотвращать, улучшать и/или лечить воспалительные состояния, включая воспалительные заболевания кишечника, способы их получения и их применения обеспечиваются.
EA201791945A 2015-07-08 2016-07-08 Пирролидинкарбоксамидо производные и способы их получения и их применение EA033342B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150097040 2015-07-08
PCT/US2016/041563 WO2017008033A1 (en) 2015-07-08 2016-07-08 Pyrrolidine carboxamido derivatives and methods for preparing and using the same

Publications (2)

Publication Number Publication Date
EA201791945A1 true EA201791945A1 (ru) 2018-06-29
EA033342B1 EA033342B1 (ru) 2019-09-30

Family

ID=57686085

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791945A EA033342B1 (ru) 2015-07-08 2016-07-08 Пирролидинкарбоксамидо производные и способы их получения и их применение

Country Status (25)

Country Link
US (3) US20170008924A1 (ru)
EP (1) EP3265443B1 (ru)
JP (1) JP6692371B2 (ru)
KR (1) KR101963559B1 (ru)
CN (2) CN107531753A (ru)
AU (1) AU2016290963B2 (ru)
BR (1) BR112017022857B1 (ru)
CA (1) CA2980001C (ru)
CL (1) CL2017002689A1 (ru)
CO (1) CO2017010530A2 (ru)
DK (1) DK3265443T3 (ru)
EA (1) EA033342B1 (ru)
ES (1) ES2784703T3 (ru)
HK (1) HK1243078A1 (ru)
IL (1) IL254327B (ru)
MX (1) MX2017013335A (ru)
MY (1) MY189670A (ru)
NZ (1) NZ735250A (ru)
PH (1) PH12017501790A1 (ru)
PL (1) PL3265443T3 (ru)
PT (1) PT3265443T (ru)
SA (1) SA517390034B1 (ru)
SG (1) SG11201707145QA (ru)
UA (1) UA121890C2 (ru)
WO (1) WO2017008033A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY189670A (en) 2015-07-08 2022-02-24 Research & Business Found Sungkyunkwan Univ Pyrrolidine carboxamido derivatives and methods for preparing and using the same
EP3759070A4 (en) * 2018-02-28 2021-12-08 Bridge Biotherapeutics, Inc. WATER-SOLUBLE SALT OF LIPIDATED PEPTIDES AND PROCESS FOR THEIR PRODUCTION AND USE
SG11202104802RA (en) * 2018-11-08 2021-06-29 Arizona Board Of Regents On Behalf Arizona State Univ Synthetic immunomodulation with a crispr super-repressor in vivo
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법
KR102268702B1 (ko) * 2019-10-17 2021-06-24 주식회사 에피바이오텍 Rip 키나아제 억제제를 포함하는 탈모 방지 또는 발모 촉진용 조성물
CN114585383B (zh) * 2019-10-17 2024-04-19 艾弼生物科技有限公司 包含rip激酶抑制剂的用于防脱发或促生发的组合物
KR102394875B1 (ko) * 2021-05-11 2022-05-06 주식회사 비드테크 피롤리딘을 링커로 포함하는 화합물 및 이를 포함하는 약학 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839127A1 (de) * 1988-11-19 1990-05-23 Hoechst Ag Pyrrolidon-2-carbonsaeure-derivate mit psychotroper wirkung
AUPM906594A0 (en) 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
EP1988078B1 (en) * 1996-05-01 2012-10-17 Ortho-McNeil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
US6114361A (en) * 1998-11-05 2000-09-05 Pfizer Inc. 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP2002297664A (ja) 2001-04-03 2002-10-11 Fuji Photo Film Co Ltd 画像データ提供装置および画像データ提供プログラム
WO2003007876A2 (en) 2001-06-25 2003-01-30 University Of Massachusetts N-fatty acid-amino acid conjugates and therapeutic uses
DE10259672A1 (de) * 2002-12-18 2004-07-01 Basf Ag Verfahren zur Herstellung von Alkoxycarbonylamino-triazinen
JP2006157623A (ja) * 2004-11-30 2006-06-15 Funai Electric Co Ltd 放送受信装置
WO2006113942A2 (en) * 2005-04-20 2006-10-26 Schering Corporation Method of inhibiting cathepsin activity
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
KR20100058541A (ko) * 2007-08-15 2010-06-03 아뮤닉스 인코포레이티드 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
CN102067197A (zh) 2008-06-26 2011-05-18 夏普株式会社 显示装置和电子设备
CN102123697B (zh) 2008-08-18 2015-06-10 安特拉贝欧有限公司 用于口服给予蛋白质的方法和组合物
KR101033041B1 (ko) 2008-11-13 2011-05-09 조선대학교산학협력단 경보장치 고정 장치
WO2010059922A1 (en) * 2008-11-21 2010-05-27 Ligand Pharmaceuticals Incorporated Pyrrolidine carboxamide compounds
KR101151878B1 (ko) 2010-06-08 2012-05-31 미원상사주식회사 지방산 트리펩타이드염 및 이를 함유하는 항균 조성물
KR20100110282A (ko) 2010-08-16 2010-10-12 황규태 쓰레기봉투용 뚜껑
KR101348284B1 (ko) * 2010-09-09 2014-01-03 주식회사 나이벡 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도
KR20120048864A (ko) 2010-11-08 2012-05-16 주식회사 네오디엠 트리 펩타이드 유도체를 함유한 아토피 피부염 예방 및 치료용 조성물과 그 제조방법
KR20130038426A (ko) 2011-10-07 2013-04-18 성균관대학교산학협력단 지방산이 결합된 항당뇨 펩티드가 소수성 결합된 글리콜 키토산 히드로겔 및 이를 포함하는 당뇨병 예방 또는 치료용 약학적 조성물
KR101359886B1 (ko) 2011-12-28 2014-02-12 성균관대학교산학협력단 스매드 6번(Ｓｍａｄ６)으로부터 유래된 펩타이드를 유효성분으로 포함하는 패혈증 또는 패혈성 쇼크의 치료용 조성물
WO2013190497A2 (en) * 2012-06-21 2013-12-27 Radikal Therapeutics Inc. Compositions and methods for treatment of inflammatory diseases of the lung
US20160228569A1 (en) * 2013-10-15 2016-08-11 S. Kenny Roberts Peptide constructs and well-defined aggregates thereof
MY189670A (en) 2015-07-08 2022-02-24 Research & Business Found Sungkyunkwan Univ Pyrrolidine carboxamido derivatives and methods for preparing and using the same

Also Published As

Publication number Publication date
MY189670A (en) 2022-02-24
PT3265443T (pt) 2020-02-14
US20180208625A1 (en) 2018-07-26
HK1243078A1 (zh) 2018-07-06
PH12017501790A1 (en) 2018-04-02
SA517390034B1 (ar) 2021-12-23
JP2018519244A (ja) 2018-07-19
CN107531753A (zh) 2018-01-02
MX2017013335A (es) 2018-06-06
CA2980001C (en) 2021-05-04
CN115368438A (zh) 2022-11-22
BR112017022857A2 (pt) 2018-07-17
EP3265443A4 (en) 2018-11-07
CO2017010530A2 (es) 2018-01-05
BR112017022857B1 (pt) 2023-09-26
NZ735250A (en) 2020-08-28
CA2980001A1 (en) 2017-01-12
SG11201707145QA (en) 2017-10-30
WO2017008033A1 (en) 2017-01-12
PL3265443T3 (pl) 2020-06-29
CL2017002689A1 (es) 2018-04-20
EA033342B1 (ru) 2019-09-30
US20170008924A1 (en) 2017-01-12
AU2016290963A1 (en) 2017-09-28
EP3265443B1 (en) 2020-01-08
US20230018246A1 (en) 2023-01-19
AU2016290963B2 (en) 2019-06-27
KR20170127000A (ko) 2017-11-20
KR101963559B1 (ko) 2019-03-28
UA121890C2 (uk) 2020-08-10
ES2784703T3 (es) 2020-09-30
IL254327A0 (en) 2017-11-30
US11365215B2 (en) 2022-06-21
JP6692371B2 (ja) 2020-05-13
EP3265443A1 (en) 2018-01-10
DK3265443T3 (da) 2020-03-09
WO2017008033A8 (en) 2017-11-16
IL254327B (en) 2021-04-29

Similar Documents

Publication Publication Date Title
EA201890307A1 (ru) Индазольные и азаиндазольные соединения как ингибиторы irak-4
EA201791945A1 (ru) Пирролидинкарбоксамидопроизводные и способы их получения и их применение
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
EA201890111A1 (ru) Замещенные производные оксопиридина
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
DK3289080T3 (da) Genterapi til autosomalt dominante sygdomme
EA201691582A1 (ru) Новые фармацевтические препараты
MX2017006302A (es) Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
ES2721001T3 (es) Derivado de isoindolina, y composiciones y métodos para tratar una enfermedad neurodegenerativa
EA201790395A1 (ru) Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201890185A1 (ru) Способы лечения опосредованных гепсидином нарушений
EA201500801A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201692143A1 (ru) Производные аминопиразина в качестве ингибиторов фосфатидилинозитол-3-киназы
EA202091731A1 (ru) Ингибиторы аутотаксина и их применения
EA201690844A1 (ru) Ингибиторы gsk-3
EA201592108A1 (ru) Гетероциклические соединения в качестве ингибиторов сигнального пути hedgehog
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
EA201691887A1 (ru) Лечение внутрипеченочных холестатических заболеваний
EA201791807A1 (ru) Новый тритерпенон по с-3 с обратными амидными производными по с-17 в качестве ингибиторов вич

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM